Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v2.4.0.6
Condensed Consolidated Statements of Operations (USD $)
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Product $ 917,929 $ 1,351,072
Recurring 1,010,672 1,131,627
Total Net Revenues 1,928,601 2,482,699
Product 600,809 708,270
Recurring 289,909 263,869
Total Cost of Sales 890,718 972,139
Gross Profit 1,037,883 1,510,560
Research and development 230,564 208,609
Selling, general and administrative 1,431,781 1,127,834
Depreciation and amortization 72,598 61,528
Total Operating Expense 1,734,943 1,397,971
Income (Loss) from Operations (697,060) 112,589
Interest expense, net (31,764) (190,234)
Gain on derivative liability   172,476
Gain on disposal of property and equipment   2,165
Gain on sale of product line   829,296
Total Other Income (Expense) (31,764) 813,703
Income (Loss) Before Provision for Income Taxes (728,824) 926,292
Provision for Income Taxes      
Net Income (Loss) (728,824) 926,292
Accretion of preferred dividends and discount (190,753) (104,899)
Net income (loss) attributable to common stockholders $ (919,577) $ 821,393
Income (loss) per common share – basic (in Dollars per share) $ (0.01) $ 0.01
Income (loss) per common share – diluted (in Dollars per share) $ (0.01) $ 0.01
Weighted Average Common Shares Outstanding – basic (in Shares) 104,351,326 101,363,617
Weighted Average Common Shares Outstanding – diluted (in Shares) 106,457,737 101,868,176